Brustia, Diego, Uglietti, Alessia, Garavelli, Pietro Luigi · Recenti progressi in medicina · 2004
This case study describes one patient with a rare condition called polyneuritis cranialis (weakness affecting multiple nerves in the head and face) that was linked to a human herpesvirus-6 (HHV-6) infection. The patient was treated with an antiviral medication called ganciclovir, and her symptoms improved only after the virus was completely cleared from her body.
Since HHV-6 has been postulated to play a role in ME/CFS pathogenesis, understanding its neurological manifestations—including effects on cranial nerves—may inform understanding of neurological symptoms reported in ME/CFS patients. This case suggests that HHV-6 can cause measurable neurological damage and may respond to antiviral therapy, relevant to ongoing investigations of viral mechanisms in ME/CFS.
This single case report does not prove that HHV-6 causes polyneuritis cranialis in general populations, nor does it establish HHV-6 as a causative agent in ME/CFS. The improvement with ganciclovir may reflect coincidental recovery, placebo effect, or other confounding factors. The case cannot determine whether HHV-6 reactivation or primary infection was responsible, or whether the association applies to other patient populations.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →